
A natural zzso zzso inhibitor of zzso zzso shows promise in ongoing phase II and III clinical trials for human prostate zzso In this study we show that zzso zzso zzso zzso in zzso zzso prostate cancer cells that have high levels of zzso and are resistant to zzso both in zzso and in zzso but not in zzso zzso cells with low zzso and sensitive to zzso The zzso inhibitor zzso zzso through blocking zzso interaction, together with zzso zzso zzso zzso and zzso the zzso zzso The zzso zzso is dependent on zzso and zzso Our results show for the first time that zzso can also interrupt the interactions between zzso and zzso at zzso zzso thus releasing the zzso zzso protein zzso which in turn triggers the zzso zzso zzso administration of zzso significantly inhibited the growth of zzso prostate cancer zzso representing a promising new regimen for the treatment of human zzso prostate cancer with zzso zzso Our data provide new insights into the mode of cell death induced by zzso zzso which will facilitate the rational design of clinical trials by selecting patients who are most likely to benefit from the zzso molecular zzso 

